National and Kapodistrian University of Athens
Ανοσοφαινοτυπική και λειτουργική μελέτη αρχέγονων αιμοποιητικών κυττάρων στο μυελό των οστών ασθενών με πρωτοπαθές μυελοδυσπλαστικό σύνδρομο
Abstract
dc:descriptionMyelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders with unknown etiology. Multiparameter flow cytometry (MFC) is being evaluated for the diagnosis and prognosis of MDS. In the present study five-color MFC was performed on bone marrow aspirates of 47 untreated patients, newly diagnosed with MDS and 27 age matched control samples. Patients were classified according to World Health Organization 2008 (WHO), International Prognostic Scoring System (IPSS) and Revised IPSS (IPSS-R). Significantly higher CD133+/CD90-CD45weak, CD117+/TdT-CD45weak and CD33+/MPO- Neutrophil Precursor (NP) percentages on CD34+ cells, as well as a significant decrease of lymphoid and erythroid precursors was observed in the group of MDS patients in comparison to controls. A new scoring system was based on these findings which can be helpful in lower-risk MDS patients’ discrimination, including those with normal karyotype (a subgroup of MDS with diagnostic challenges). In addition, an increased level of apoptosis of CD34+/CD117+ cells was identified as an independent favorable prognostic factor both for the risk of transformation to AML and for overall survival. A new scoring system based on the expression of immature cell antigens on CD34+ cells (by itself or in combination with the Ogata score) can discriminate lower-risk MDS patients, including those with normal karyotype, from the normal control group.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gardikas, Nikolaos
- Γαρδίκας, Νικόλαος
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44891